CARE Series: Culturally Responsive Treatment for Substance Use Disorders

Thursday, January 9, 2025, 12:00 PM - Sunday, January 9, 2028, 1:00 PM

AMA PRA Category 1 Credits™ (1.00 hours), ANCC Nursing Contact Hours (1.00 hours), CME-Designated Participation Credit (1.00 hours)

Review of evidence and opportunities for interdisciplinary care teams regarding:

• Culturally responsive interventions for substance use disorders.

• Clinical practice recommendations for a culturally informed, whole-person approach to Medications for Opioid Use Disorder care.

• Resources for SUD care teams treating specific minoritized populations.

This webinar will serve as an introduction to the application of traditional, complementary and integrative medicine in clinical care for people experiencing substance use disorders. Specifically, we will highlight the role of mindfulness and acupuncture in treatment approaches. 

Presenter

Avik Chatterjee, MD, MPH 
Assistant Professor of Medicine,
Boston University Chobanian & Avedisian School of Medicine

Dr. Chatterjee is a med-peds trained primary care and addiction medicine physician at several shelter-based clinics through Boston Health Care for the Homeless Program. His areas of clinical and research interest include innovative treatment models for opioid use disorder in marginalized populations, and interventions on social determinants of health, such as food insecurity. He has an additional interest in racism and health care, particularly its manifestations in medical education and training.

1. Outline one culturally responsive intervention for substance use disorders.
2. Summarize three clinical practice recommendations for a culturally informed, whole-person approach to Medications for Opioid Use Disorder (MOUD) care.
3. Pair implementation tasks for one clinical practice recommendation for culturally informed MOUD delivery to an appropriate health care discipline.

In support of improving patient care, Dartmouth Health is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 

American Medical Association (AMA)
Dartmouth Health designates this Enduring Material for a maximum of 1.00 AMA PRA Category 1 Credits^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

American Nurses Credentialing Center (ANCC)
Dartmouth Health designates this Enduring Material for a maximum of 1.00 ANCC contact hours. 

All other learners may claim CME-designated participation credit. Consult your professional licensing board regarding the applicability and acceptance of CME-designated participation credit for programs certified for credit by organizations accredited by Joint Accreditation for Interprofessional Education.

Registration/Requirements for Successful Completion
You may claim credit for successful completion of this online course. In order to claim credit, you must follow these steps:

1. Click the Register tab above. If you are not logged into your account, you will need to log in. Use the Forgot Your Password? button if you need to reset your password.

2. Register for the activity.

3. Click the Content/Tests tab and then View Content to view the recording. View the entire presentation.

4. Complete the Post-Test (attestation - return to the Content/Tests tab to find it).

5. Click the Complete Evaluation button, or click My Account in the menu bar; then click Evaluations.

6. Complete and Submit the Evaluation.

Bibliographic Material

• Ascunce Gonzalez K, Swartz N, Linares MA, Gelpí-Acosta C, Chatterjee A. Latine perspectives on the impact of family, perceptions of medication, health systems, incarceration, and housing on accessing opioid agonist therapy: A thematic analysis. J Subst Use Addict Treat. 2024 Dec;167:209491. https://doi.org/10.1016/j.josat.2024.209491. Epub 2024 Aug 22.

• Bonczar, T. P. & United States Bureau Of Justice Statistics. (2003) Prevalence of imprisonment in the U.S. population, -2001. Washington, D.C.: U.S. Dept. of Justice, Office of Justice Programs. [Pdf] Retrieved from the Library of Congress, https://www.loc.gov/item/2003373566/.

• Britz JB, O'Loughlin KM, Henry TL, Richards A, Sabo RT, Saunders HG, Tong ST, Brooks EM, Lowe J, Harrell A, Bethune C, Moeller FG, Krist AH. Rising Racial Disparities in Opioid Mortality and Undertreatment of Opioid Use Disorder and Mental Health Comorbidities in Virginia. AJPM Focus. 2023 Apr 27;2(3):100102. https://doi.org/10.1016/j.focus.2023.100102. PMID: 37790667; PMCID: PMC10546578.

• Bronfenbrenner, U. (1979). The Ecology of Human Development: Experiments by Nature and Design. Cambridge, MA: Harvard University Press.

• Drug Policy Alliance, 2016. White Faces, Black Lives: Race and Reparative Justice in the Era of the Gentler War on Drugs, Drug Policy Alliance Conference. https://drugpolicy.org/resource/white-faces-black-lives-race-and-reparative-justice-in-the-era-of-a-gentler-war-on-drugs/

• Dumont, D.M., et al., Public Health and the Epidemic of Incarceration. Annual Review of Public Health, 2012. 33(Volume 33, 2012): p. 325-339.

• Ford CL, Airhihenbuwa CO. The public health critical race methodology: praxis for antiracism research. Soc Sci Med. 2010 Oct;71(8):1390-8. https://doi.org/10.1016/j.socscimed.2010.07.030. Epub 2010 Aug 11. PMID: 20822840.

• Goedel WC, Shapiro A, Cerdá M, Tsai JW, Hadland SE, Marshall BDL. Association of Racial/Ethnic Segregation With Treatment Capacity for Opioid Use Disorder in Counties in the United States. JAMA Netw Open. 2020 Apr 1;3(4):e203711. https://doi.org/10.1001/jamanetworkopen.2020.3711. PMID: 32320038; PMCID: PMC7177200.

• Hansen H, Netherland J. Is the Prescription Opioid Epidemic a White Problem? Am J Public Health. 2016 Dec;106(12):2127-2129. https://doi.org/10.2105/AJPH.2016.303483. PMID: 27831792; PMCID: PMC5105018.

• Lagisetty PA, Ross R, Bohnert A, Clay M, Maust DT. Buprenorphine Treatment Divide by Race/Ethnicity and Payment. JAMA Psychiatry. 2019 Sep 1;76(9):979-981. https://doi.org/10.1001/jamapsychiatry.2019.0876. PMID: 31066881; PMCID: PMC6506898

• Netherland J, Hansen HB. The War on Drugs That Wasn't: Wasted Whiteness, "Dirty Doctors," and Race in Media Coverage of Prescription Opioid Misuse. Cult Med Psychiatry. 2016 Dec;40(4):664-686. https://doi.org/10.1007/s11013-016-9496-5. PMID: 27272904; PMCID: PMC5121004.

• Saneta deVuono-powell, Chris Schweidler, Alicia Walters, and Azadeh Zohrabi. Who Pays? The True Cost of Incarceration on Families. Oakland, CA: Ella Baker Center, Forward Together, Research Action Design, 2015.

Provider Contact Information
Provider contact information for questions regarding accreditation of the activity:

Center for Learning and Professional Development
ACE Office
Dartmouth Health
[email protected]

You are not logged in.

Please click the button below to login or create a new account before continuing.

Mitigation of Relevant Financial Relationships

Dartmouth Health adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education.  Any individuals in a position to control the content of a CE activity, including planners, faculty, authors, or others are required to disclose all financial relationships with ineligible companies^.  All relevant financial relationships have been mitigated prior to the commencement of the activity.

^Ineligible Company is any entity whose primary business purpose is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients.